🇺🇸 FDA
Pipeline program

INSULIN GLARGINE

LPS17375

Approved small_molecule active

Quick answer

INSULIN GLARGINE for Diabetes mellitus II is a Approved program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Diabetes mellitus II
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials